½ÃÀ庸°í¼­
»óǰÄÚµå
1576557

¼¼°èÀÇ ºÒÀÓÄ¡·á °ü±¤ ½ÃÀå : Ä¡·á À¯Çüº°, ¼­ºñ½º À¯Çüº°, ȯÀÚ À¯Çüº°, ¿¬·ÉÃþº°, ¼ÒµæÃþº°, ¼­ºñ½º Á¦°ø¾÷üº°, Ä¡·á ÁÖ±âÀÇ ±æÀ̺° ¿¹Ãø(2025-2030³â)

Fertility Tourism Market by Treatment Type (Fertility Preservation, Gamete Donation, In-Vitro Fertilization ), Service Type, Patient Type, Age Group, Income Group, Service Provider, Treatment Cycle Length - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 190 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ºÒÀÓÄ¡·á °ü±¤ ½ÃÀåÀº 2023³â 4¾ï 928¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 4¾ï 6,318¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 10.86%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 8¾ï 4,229¸¸ ´Þ·¯·Î µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÇ·á °ü±¤ÀÇ ÇÑ ¿ä¼ÒÀÎ ºÒÀÓ Ä¡·á °ü±¤¿¡´Â ü¿Ü¼öÁ¤(IVF), ³­ÀÚ Á¦°ø, ´ë¸® Ãâ»ê µî »ý½Ä ÀÇ·á ¼­ºñ½º¸¦ ¹Þ±â À§ÇØ ¿Ü±¹À¸·Î ¿©ÇàÇÏ´Â °³ÀÎÀÌ Æ÷ÇԵ˴ϴÙ. ºÒÀÓÄ¡·á °ü±¤ÀÇ Çʿ伺Àº ¼¼°èÀÇ ºÒÀÓ·ü »ó½Â, ±âÁõÀÚ°¡ µÇ´Â ³­ÀÚ¿Í Á¤ÀÚÀÇ ºÎÁ·, ÀÚ±¹ ½ÃÀå¿¡¼­ÀÇ ¹ýÀû Á¦¾à, °íµµ »ý½Ä±â¼úÀÇ Ãß±¸¿¡ ÀÇÇØ ÃÊ·¡µË´Ï´Ù. ±× ¿ëµµ´Â ºÒÀÓ Ä¡·á¸¦ Ãß±¸ÇÏ´Â °³ÀÎÀ̳ª Ä¿Çÿ¡°Ô±îÁö ±×¸®°í °¡Á¤¿¡¼­ÀÇ °æÁ¦Àû, ¹ýÀû, ÀÇÇÐÀû À庮¿¡µµ ºÒ±¸ÇÏ°í ±×µé¿¡°Ô ºÎ¸ð°¡ µÉ ±âȸ¸¦ ÁÝ´Ï´Ù. ÃÖÁ¾ ¿ëµµ´Â ºÒÀÓ Ä¡·á Àü¹® Ŭ¸®´Ð¿¡¼­ »ý½Ä ÀÇ·á Àü¹® ºÎ¹®À» °¡Áø ´ëº´¿ø¿¡ À̸£±â±îÁö ¼¼°èÀûÀ¸·Î ´Ù¾çÇÕ´Ï´Ù. ¼ºÀå¿äÀÎÀ¸·Î´Â ºÒÀÓÄ¡·á±â¼úÀÇ Áøº¸, ¸¸È¥È­·ÎÀÇ »çȸÀû ½ÃÇÁÆ®, °¡Ã³ºÐ¼Òµæ Áõ°¡, ÇØ¿ÜµµÇ×À» ¿ëÀÌÇÏ°Ô ÇÏ´Â Ç×°ø¿îÀÓÀÇ ÀÎÇÏ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. °³º°È­µÈ ºÒÀÓ Ä¡·á ÆÐŰÁö Á¦°ø, ¼º°ø·üÀ» ³ôÀ̱â À§ÇÑ AI µµÀÔ, ȯÀÚ °æÇèÀ» Çâ»ó½Ã۱â À§ÇÑ Á¢°´ °ü±¤ ºÎ¹®°úÀÇ Á¦ÈÞ µî »õ·Î¿î ºñÁî´Ï½º ±âȸ°¡ Á¸ÀçÇÕ´Ï´Ù. ±×·¯³ª ±ÔÁ¦¿Í À±¸®Àû ¿ì·Á, ´ë¸®¸ðÀÇ ÂøÃë °¡´É¼º, ±¹Á¦ ¾î¸°ÀÌÀÇ Ä£±Ç¿¡ °üÇÑ ¹ýÀû º¹À⼺, Àú¼Òµæ ȯÀÚÀÇ ¼Ò¿Ü µîÀÌ ÇѰè·Î ²ÅÈü´Ï´Ù. °úÁ¦´Â ´Ù¾çÇÑ ±¹Á¦ Ç¥ÁØ ¹× ƯÈ÷ ±â¹Ð¼ºÀÌ ³ôÀº À¯Àü ¹°Áú¿¡ ´ëÇÑ ¾ö°ÝÇÑ µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ´ëÃ¥ÀÇ Çʿ伺À¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. À¯ÀüÀÚ ½ºÅ©¸®´×, Áö¼Ó °¡´ÉÇÑ ´ë¸® Ãâ»ê °üÇà, ¹°¸®Àû µµÂø Àü¿¡ °í°´À» ¼ö¿ëÇϱâÀ§ÇÑ ¿ø°Ý ÀÇ·á »ó´ã°ú °°Àº Çõ½ÅÀº ºñÁî´Ï½º ¼ºÀåÀ» °¡¼ÓÇÒ ¼ö ÀÖ½À´Ï´Ù. Åõ¸í¼ºÀ» ÃËÁøÇϰí ÇöÁö ±ÔÁ¦¿¡ ´ëÇÑ ±³À°Àº ½Å·Ú¸¦ ³ôÀÌ°í ±â¼ú ÅëÇÕÀº ¼­ºñ½º Á¦°øÀ» °£¼ÒÈ­ÇÕ´Ï´Ù. ¸Å¿ì ¼¼ºÐÈ­µÇ°í ÇöÁö ¹ý·ü, À±¸®Àû ¿ì·Á, ±â¼ú ¹ßÀüÀÇ ¿µÇâÀ» ¹Þ´Â ÀÌ ½ÃÀåÀÇ ¼º°ÝÀ» ÀÌÇØÇÏ´Â °ÍÀº °æÀï·Â ÀÖ´Â ¼­ºñ½º¿Í À±¸®Àû °üÇàÀÇ ±ÕÇüÀ» À¯ÁöÇϸ鼭 ºÒÀÓ Ä¡·á Åõ¾î¸®Áò¿¡¼­ÀÇ Å« ¼ºÀåÀ» ¸ñÇ¥·Î ÀÌÇØ °ü°èÀÚ¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 4¾ï 928¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ (2024) 4¾ï 6,318¸¸ ´Þ·¯
¿¹Ãø³â(2030) 8¾ï 4,229¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 10.86%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ºÒÀÓ Ä¡·á °ü±¤ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ºÒÀÓ Ä¡·á °ü±¤ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿Àû ÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ðÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ȹµæÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ëÀ̳ª ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ´Ù¾çÇÑ Ãþ°ú Áö¿ª¿¡¼­ ºÒÀÓ Ä¡·á¿¡ ´ëÇÑ Àνİú ¼ö¿ë Áõ°¡
    • ÀÇ·á±â¼ú°ú ºÒÀÓÄ¡·áÀÇ Áøº¸¿¡ ÀÇÇÑ ¼º°ø·üÀÇ Çâ»ó
    • ÇÕ¸®ÀûÀÎ °¡°ÝÀ¸·Î Á¾ÇÕÀûÀÎ Ä¡·á ÆÐŰÁö¸¦ Á¦°øÇÏ´Â ºÒÀÓ Ä¡·á Ŭ¸®´Ð Áõ°¡
    • Àü¹®ÀûÀÎ ºÒÀÓ Ä¡·á¹ýÀ» ÇÊ¿ä·Î ÇÏ´Â °í·É Ãâ»êÀÇ °æÇâÀÌ ³ô¾ÆÁ®
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¿©ÇàÀ̳ª ¹°·ù ¹®Á¦
  • ½ÃÀå ±âȸ
    • ÇÕ¸®ÀûÀÎ °¡°ÝÀ¸·Î °íǰÁúÀÇ ºÒÀÓ Ä¡·á¸¦ Á¦°øÇÏ´Â ¿©ÇàÁö Áõ°¡
    • ºÒÀÓ Ä¡·á Ŭ¸®´Ð°ú ¿©Çà»çÀÇ Á¦ÈÞ¿¡ ÀÇÇÑ È¯ÀÚ Ã¼ÇèÀÇ Çâ»ó
    • ÀÇ·á¿Í ·¹Àú¸¦ Á¶ÇÕÇÑ Çõ½ÅÀûÀÎ ºÒÀÓ Ä¡·á ÆÐŰÁö
  • ½ÃÀåÀÇ °úÁ¦
    • ÀÇ·á ±âÁذú ±ÔÁ¦ÀÇ º¯µ¿

Porter's Five Forces: ºÒÀÓ Ä¡·á °ü±¤ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÆÄ¾ÇÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂûÀ» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ºÒÀÓ Ä¡·á °ü±¤ ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ºÒÀÓ Ä¡·á °ü±¤ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ºÒÀÓ Ä¡·á °ü±¤ ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

ºÒÀÓ Ä¡·á °ü±¤ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­ ¹× ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í °ø±Þ¾÷ü´Â °æÀïÀÌ Ä¡¿­ÇØÁö¸é¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ºÒÀÓ Ä¡·á °ü±¤ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ºÒÀÓ Ä¡·á °ü±¤ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ ºÒÀÓ Ä¡·á Åõ¾î¸®Áò ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

ºÒÀÓ Ä¡·á Åõ¾î¸®Áò ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ´Ù¾çÇÑ Àα¸ÃþÀ̳ª Áö¿ª¿¡¼­ ºÒÀÓ Ä¡·á¿¡ ´ëÇÑ Àνİú ¼ö¿ëÀÌ ³ô¾ÆÁø´Ù
      • ÀÇ·á±â¼ú°ú ºÒÀÓÄ¡·áÀÇ Áøº¸¿¡ ÀÇÇØ ¼º°ø·üÀÌ »ó½Â
      • ÇÕ¸®ÀûÀÎ °¡°ÝÀ¸·Î Á¾ÇÕÀûÀÎ Ä¡·á ÆÐŰÁö¸¦ Á¦°øÇÏ´Â ºÒÀÓ Ä¡·á Ŭ¸®´Ð Áõ°¡
      • Àü¹®ÀûÀÎ ºÒÀÓ Ä¡·á ¼Ö·ç¼ÇÀ» ÇÊ¿ä·Î ÇÏ´Â ³ëÀÎ ºÎ¸ð Áõ°¡ °æÇâ
    • ¾ïÁ¦¿äÀÎ
      • ¿©Çà°ú ¹°·ù¿¡ °üÇÑ ¹®Á¦
    • ±âȸ
      • ÇÕ¸®ÀûÀÎ °¡°ÝÀ¸·Î °íǰÁúÀÇ ºÒÀÓ Ä¡·á¸¦ Á¦°øÇÏ´Â ½ÅÈï ¸ñÀûÁö
      • ºÒÀÓ Ä¡·á Ŭ¸®´Ð°ú °ü±¤ ´ë¸®Á¡ÀÇ Á¦ÈÞ¿¡ ÀÇÇØ ȯÀÚÀÇ Ã¼ÇèÀ» Çâ»ó
      • ÀÇ·á¿Í ·¹Àú¸¦ Á¶ÇÕÇÑ Çõ½ÅÀûÀÎ ºÒÀÓ Ä¡·á ÆÐŰÁö
    • °úÁ¦
      • ÀÇ·á ±âÁذú ±ÔÁ¦ÀÇ º¯µ¿
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ºÒÀÓÄ¡·á °ü±¤ ½ÃÀåÄ¡·áÀ¯Çüº°

  • »ý½Ä ´É·ÂÀÇ º¸Á¸
    • ³­ÀÚÀÇ µ¿°á
    • ¹è¾Æ µ¿°á
    • Á¤ÀÚÀÇ µ¿°á
  • ¹è¿ìÀÚ Á¦°ø
    • ³­ÀÚÁ¦°ø
    • ¹è¾Æ Á¦°ø
    • Á¤ÀÚÁ¦°ø
  • ü¿Ü¼öÁ¤(IVF)(IVF)
    • Á¾·¡ÀÇ Ã¼¿Ü¼öÁ¤(IVF)
    • ¹Ì´Ï ü¿Ü¼öÁ¤(IVF)
    • ÀÚ¿¬ÁÖ±â ü¿Ü¼öÁ¤(IVF)
  • ³­¼¼Æ÷Áú³»Á¤ÀÚÁÖÀÔ¹ý(ICSI)
  • ´ë¸® Ãâ»ê

Á¦7Àå ºÒÀÓ Ä¡·á Åõ¾î¸®Áò ½ÃÀå : ¼­ºñ½º À¯Çüº°

  • »ó´ã ¼­ºñ½º
  • ÈÄ¼Ó ¼­ºñ½º
  • ¹°·ù ¼­ºñ½º
    • ¼÷¹Ú Áغñ
    • ¹ýÀû Áö¿ø
    • ¿©Çà Áغñ
  • ÀÇ·á ¼­ºñ½º
  • Áö¿ø ¼­ºñ½º

Á¦8Àå ºÒÀÓÄ¡·á °ü±¤ ½ÃÀå ȯÀÚ À¯Çüº°

  • Ä¿ÇÃ
  • LGBTQÀÇ »ç¶÷µé
  • µ¶½Å ³²¼º
  • ½Ì±Û ¿©¼º

Á¦9Àå ºÒÀÓÄ¡·á °ü±¤ ½ÃÀå : ¿¬·ÉÃþº°

  • 20-29
  • 30-39
  • 40-49
  • 50¼¼ ÀÌ»ó

Á¦10Àå ºÒÀÓÄ¡·á °ü±¤½Ã Àå¼Òµæ ±×·ìº°

  • °í¼Òµæ
  • Àú¼Òµæ
  • Áß¼ÒµæÃþ

Á¦11Àå ºÒÀÓÄ¡·á °ü±¤ ½ÃÀå ¼­ºñ½º Á¦°ø¾÷üº°

  • ºÒÀÓ Ä¡·á Ŭ¸®´Ð
  • º´¿ø
  • Àü¹®¼¾ÅÍ

Á¦12Àå ºÒÀÓ Ä¡·á Åõ¾î¸®Áò ½ÃÀå Ä¡·á »çÀÌŬÀÇ ±æÀ̺°

  • Àå±â
  • Áß±â
  • ´Ü±â

Á¦13Àå ¾Æ¸Þ¸®Ä«ÀÇ ºÒÀÓÄ¡·á °ü±¤ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦14Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ºÒÀÓÄ¡·á °ü±¤ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦15Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ºÒÀÓ Ä¡·á Åõ¾î¸®Áò ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦16Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È
BJH 24.10.31

The Fertility Tourism Market was valued at USD 409.28 million in 2023, expected to reach USD 463.18 million in 2024, and is projected to grow at a CAGR of 10.86%, to USD 842.29 million by 2030.

Fertility tourism, a component of medical tourism, involves individuals traveling to foreign countries to access reproductive health services, such as IVF, egg donation, and surrogacy, often due to lower costs, shorter wait times, or access to services unavailable in their home country. The necessity of fertility tourism is driven by the rising global infertility rates, shortages of donor eggs or sperm, legal constraints in home markets, and the quest for advanced reproductive technologies. Its applications extend to individuals or couples seeking fertility treatments, giving them a chance to become parents despite financial, legal, or medical barriers at home. End-use scope varies widely, from specialized fertility clinics to large hospitals with dedicated reproductive health departments globally. Influencing growth factors include advancing fertility technologies, societal shifts towards later parenthood, increased disposable incomes, and reduced airline costs, facilitating easier international travel. Emerging opportunities exist in offering personalized fertility treatment packages, incorporating AI for enhanced success rates, and establishing partnerships with hospitality and tourism sectors to improve patient experiences. However, limitations include regulatory and ethical concerns, potential exploitation of surrogate mothers, legal complications related to international child custody, and the marginalization of low-income patients. Challenges arise from varying international standards and the need for stringent data privacy measures, especially concerning sensitive genetic material. Innovating in genetic screening, sustainable surrogacy practices, and telemedicine consultations to cater to clients before their physical arrival can foster business growth. Promoting transparency and educating about local regulations will enhance trust, while tech integration can streamline service delivery. Understanding the nature of this market, which is highly fragmented and influenced by local laws, ethical concerns, and technological advancements, is essential for stakeholders aiming to achieve substantial growth in fertility tourism by balancing competitive offerings with ethical practices.

KEY MARKET STATISTICS
Base Year [2023] USD 409.28 million
Estimated Year [2024] USD 463.18 million
Forecast Year [2030] USD 842.29 million
CAGR (%) 10.86%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Fertility Tourism Market

The Fertility Tourism Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing awareness and acceptance of fertility treatments across various demographics and regions
    • Advancements in medical technologies and fertility treatments leading to higher success rates
    • Rising number of fertility clinics offering affordable and comprehensive treatment packages
    • Growing trend of older parenthood requiring specialized fertility solutions
  • Market Restraints
    • Travel and logistical issues
  • Market Opportunities
    • Emerging destinations offering affordable and high-quality fertility treatments
    • Partnerships between fertility clinics and tourism agencies to enhance patient experience
    • Innovative fertility treatment packages that combine medical care with leisure activities
  • Market Challenges
    • Variability in medical standards and regulations

Porter's Five Forces: A Strategic Tool for Navigating the Fertility Tourism Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Fertility Tourism Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Fertility Tourism Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Fertility Tourism Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Fertility Tourism Market

A detailed market share analysis in the Fertility Tourism Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Fertility Tourism Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Fertility Tourism Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Fertility Tourism Market

A strategic analysis of the Fertility Tourism Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fertility Tourism Market, highlighting leading vendors and their innovative profiles. These include Barbados Fertility Centre, Cook Medical, CooperSurgical, Cross Border Reproductive Care, Cryos International, Ferring Pharmaceuticals, Fertility Associates, Genea Limited, Irvine Scientific, IVI-RMA Global, London Fertility Centre, Merck KGaA, Nova IVF, Ovation Fertility, Progyny, Sanatorium Helios, Servy Massey Fertility Institute, The Fertility Institutes, Travel for Treatment, and Vitrolife.

Market Segmentation & Coverage

This research report categorizes the Fertility Tourism Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment Type, market is studied across Fertility Preservation, Gamete Donation, In-Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Surrogacy. The Fertility Preservation is further studied across Egg Freezing, Embryo Freezing, and Sperm Freezing. The Gamete Donation is further studied across Egg Donation, Embryo Donation, and Sperm Donation. The In-Vitro Fertilization (IVF) is further studied across Conventional IVF, Mini IVF, and Natural Cycle IVF.
  • Based on Service Type, market is studied across Counseling Services, Follow-Up Services, Logistics Services, Medical Services, and Support Services. The Logistics Services is further studied across Accommodation Arrangements, Legal Assistance, and Travel Arrangements.
  • Based on Patient Type, market is studied across Couples, LGBTQ+ Individuals, Single Men, and Single Women.
  • Based on Age Group, market is studied across 20-29, 30-39, 40-49, and 50 and Above.
  • Based on Income Group, market is studied across High Income, Low Income, and Middle Income.
  • Based on Service Provider, market is studied across Fertility Clinics, Hospitals, and Specialty Centers.
  • Based on Treatment Cycle Length, market is studied across Long Term, Medium Term, and Short Term.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing awareness and acceptance of fertility treatments across various demographics and regions
      • 5.1.1.2. Advancements in medical technologies and fertility treatments leading to higher success rates
      • 5.1.1.3. Rising number of fertility clinics offering affordable and comprehensive treatment packages
      • 5.1.1.4. Growing trend of older parenthood requiring specialized fertility solutions
    • 5.1.2. Restraints
      • 5.1.2.1. Travel and logistical issues
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging destinations offering affordable and high-quality fertility treatments
      • 5.1.3.2. Partnerships between fertility clinics and tourism agencies to enhance patient experience
      • 5.1.3.3. Innovative fertility treatment packages that combine medical care with leisure activities
    • 5.1.4. Challenges
      • 5.1.4.1. Variability in medical standards and regulations
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Fertility Tourism Market, by Treatment Type

  • 6.1. Introduction
  • 6.2. Fertility Preservation
    • 6.2.1. Egg Freezing
    • 6.2.2. Embryo Freezing
    • 6.2.3. Sperm Freezing
  • 6.3. Gamete Donation
    • 6.3.1. Egg Donation
    • 6.3.2. Embryo Donation
    • 6.3.3. Sperm Donation
  • 6.4. In-Vitro Fertilization (IVF)
    • 6.4.1. Conventional IVF
    • 6.4.2. Mini IVF
    • 6.4.3. Natural Cycle IVF
  • 6.5. Intracytoplasmic Sperm Injection (ICSI)
  • 6.6. Surrogacy

7. Fertility Tourism Market, by Service Type

  • 7.1. Introduction
  • 7.2. Counseling Services
  • 7.3. Follow-Up Services
  • 7.4. Logistics Services
    • 7.4.1. Accommodation Arrangements
    • 7.4.2. Legal Assistance
    • 7.4.3. Travel Arrangements
  • 7.5. Medical Services
  • 7.6. Support Services

8. Fertility Tourism Market, by Patient Type

  • 8.1. Introduction
  • 8.2. Couples
  • 8.3. LGBTQ+ Individuals
  • 8.4. Single Men
  • 8.5. Single Women

9. Fertility Tourism Market, by Age Group

  • 9.1. Introduction
  • 9.2. 20-29
  • 9.3. 30-39
  • 9.4. 40-49
  • 9.5. 50 and Above

10. Fertility Tourism Market, by Income Group

  • 10.1. Introduction
  • 10.2. High Income
  • 10.3. Low Income
  • 10.4. Middle Income

11. Fertility Tourism Market, by Service Provider

  • 11.1. Introduction
  • 11.2. Fertility Clinics
  • 11.3. Hospitals
  • 11.4. Specialty Centers

12. Fertility Tourism Market, by Treatment Cycle Length

  • 12.1. Introduction
  • 12.2. Long Term
  • 12.3. Medium Term
  • 12.4. Short Term

13. Americas Fertility Tourism Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Fertility Tourism Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Fertility Tourism Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2023
  • 16.2. FPNV Positioning Matrix, 2023
  • 16.3. Competitive Scenario Analysis
  • 16.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Barbados Fertility Centre
  • 2. Cook Medical
  • 3. CooperSurgical
  • 4. Cross Border Reproductive Care
  • 5. Cryos International
  • 6. Ferring Pharmaceuticals
  • 7. Fertility Associates
  • 8. Genea Limited
  • 9. Irvine Scientific
  • 10. IVI-RMA Global
  • 11. London Fertility Centre
  • 12. Merck KGaA
  • 13. Nova IVF
  • 14. Ovation Fertility
  • 15. Progyny
  • 16. Sanatorium Helios
  • 17. Servy Massey Fertility Institute
  • 18. The Fertility Institutes
  • 19. Travel for Treatment
  • 20. Vitrolife
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦